Trial
NCT04605588
A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Rutgers, The State University of New Jersey
Collaborators
SynaVir
Condition
SARS-CoV Infection
Intervention
Nitazoxanide
Why stopped
Lack of participants willing to enroll
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-05